@misc{bae5c4635600430c8dee3f254b47c0c1,
title = "白及萃取物治療嗜中性白血球活化失調相關疾病的用途",
abstract = "本文揭示一種用以治療因嗜中性白血球活化及趨化失調所致相關疾病的方法。該方法包括向有此需要的個體投予有效量的台灣白及萃取物，其至少包含 3,3{\textquoteright}-二羥基-5-甲氧聯苄基(山藥素III), 9,10-二氫-1-[(4-羥苯基)甲基]-4-甲氧基-2,7-菲二醇(Orchidble), 3',5-二甲氧基-3-羥聯苄基(BF8-4-2), 3,5-二甲氧基-3'-羥聯苄基 (BF8-4-3) 和 3-羥基-5-甲氧基聯苄基 (BF8-4-4)。",
keywords = "or disorders associated with the dysregulated activation and recruitment of neutrophils. The method includes administering to a subject in need thereof an effective amount of an extract of Bletilla formosana.The Bletilla formosanaextract includes, at least, compounds of 3,3{\textquoteright}-dihydroxy-5-methoxybibenzyl (Batatacin III), 9,10-dihydro-1-[(4-hydroxyphenyl)methyl]-4-methoxy-2,7-phenanthrenediol (Orchidble), 3',5-dimethoxy-3-hydroxybibenzyl (BF8-4-2), 3,5-dimethoxy-3'-hydroxybibenzyl (BF8-4-3) and 3-hydroxy-5-methoxybibenzyl (BF8-4-4).",
author = "Tsong-Long Hwang and WU-DAI-YU JIANG and YU-CHIA CHANG",
note = "A61K 36/898(2006.01); A61K 31/085(2006.01); A61P 1/16(2006.01); A61P 3/10(2006.01); A61P 11/00(2006.01); A61P 17/06(2006.01)",
year = "2023",
month = oct,
day = "1",
language = "繁體中文",
type = "Patent",
}